Precision Biosciences (DTIL) Current Leases (2020 - 2026)

Precision Biosciences (DTIL) has 7 years of Current Leases data on file, last reported at $1.6 million in Q1 2026.

• On a quarterly basis, Current Leases rose 14.07% year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was $1.6 million, a 14.07% increase from a year earlier, with the FY2025 full-year figure at $1.5 million, up 14.17% from the prior year.
• Current Leases for Q1 2026 stood at $1.6 million, up from $1.5 million in the prior quarter.
• Over the last five years, Current Leases for DTIL reached as high as $2.5 million in Q2 2023 and fell as low as $1.1 million in Q4 2023.
• Historically, Current Leases has averaged $1.6 million across 5 years, with a median of $1.5 million in 2023.
• Across the five-year window, Current Leases rose 29.68% in 2023 and tumbled 51.06% in 2024, its largest moves.
• Year by year, Current Leases stood at $1.7 million in 2022, then slumped by 32.48% to $1.1 million in 2023, then increased by 16.5% to $1.3 million in 2024, then gained by 14.17% to $1.5 million in 2025, then increased by 3.32% to $1.6 million in 2026.
• Per Business Quant data, the three most recent Current Leases figures were $1.6 million in Q1 2026, $1.5 million in Q4 2025, and $1.5 million in Q3 2025.